Client News
Roquefort Investments plc: Reverse Takeover Transaction and Suspension of TradingRoquefort Investments (LSE:ROQ), the investment company established to acquire businesses focused on early-stage opportunities in the medical biotechnology sector, is pleased to announce that the Company has entered into a non-binding term sheet (the “Term Sheet”) with Provelmare Holding S.A. (“Provelmare”) pursuant to which Roquefort Investments will acquire 100% of the total issued equity in Lyramid Limited (“Lyramid”) for an initial consideration of £1 million payable 50% in cash and 50% in shares (the “Transaction”). Lyramid has the exclusive worldwide licence to commercialise up to 37 patents related to Midkine-based therapies for the treatment of COVID-19 patients, cancer, autoimmune disorders and chronic kidney disease (“Midkine-Based Therapies”).
https://www.londonstockexchange.com/news-article/ROQ/reverse-takeover-suspension-of-trading/15153332
OPEN AN ACCOUNT
If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.
CLIENT AREA
Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.